Immunometabolic drivers of metabolic dysfunction-associated steatotic liver disease in non-obese people living with human immunodeficiency virus

doi:10.3748/wjg.120036

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 32, Issue 41

This Article

(16)

(14)

(0)

(247)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.

World J Gastroenterol. Nov 7, 2026; 32(41): 120036
Published online Nov 7, 2026. doi: 10.3748/wjg.120036

Full Size Figure Download Figure

Figure 2 Adjusted multivariate logistic regression analysis of metabolic dysfunction-associated steatotic liver disease risk factors in overall human immunodeficiency virus patients. Variables included in the model are gender, age, group, body mass index, alanine aminotransferase, high-density lipoprotein, triglyceride-glucose, glucose, cluster of differentiation (CD) 4 cell count ≥ 350 cells/μL, and CD4/CD8 ratio. OR: Odds ratio; CI: Confidence interval; BMI: Body mass index; HDL: High-density lipoprotein; ALT: Alanine aminotransferase; TyG: Triglyceride-glucose.

Citation: Ji F, Zhang LF, Gui Y, Qi ZH, Han Y, Su N, Zhang Q, Li YL, Zhao W, Lyu W, Yang M. Immunometabolic drivers of metabolic dysfunction-associated steatotic liver disease in non-obese people living with human immunodeficiency virus. World J Gastroenterol 2026; 32(41): 120036
URL: https://www.wjgnet.com/1007-9327/full/v32/i41/120036.htm
DOI: https://dx.doi.org/10.3748/wjg.120036

Ji F, Zhang LF, Gui Y, Qi ZH, Han Y, Su N, Zhang Q, Li YL, Zhao W, Lyu W, Yang M. Immunometabolic drivers of metabolic dysfunction-associated steatotic liver disease in non-obese people living with human immunodeficiency virus. World J Gastroenterol 2026; 32(41): 120036 [DOI: 10.3748/wjg.120036]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.